| SOXS 1.79 0.51% | TPET 1.12 166.67% | NVDA 182.48 2.99% | ONDS 10.67 5.85% | STAK 1.04 144.71% | XLE 57.035 1.99% | BITO 9.53 5.19% | TMDE 3.06 231.82% | NVD 7.09 -5.84% | TZA 6.06 -2.73% | NOK 8.26 6.99% | DUST 3.58 1.13% | TURB 1.37 102.84% | F 13.39 -4.97% | TQQQ 49.7 0.36% | RYDE 0.4628 100.00% | PLUG 1.81 1.12% | IBIT 39.213 5.44% | SLV 81.57 -4.02% | EONR 0.5056 17.04% | BHAT 0.039 -21.21% | MSTX 2.51 11.56% | AAL 12.52 -4.21% | TSLS 5.63 -0.18% | SPY 686.34 0.05% | USEG 1.17 9.35% | SOXL 62.76 -0.02% | AES 14.21 -17.77% | NU 15.19 1.40% | NFLX 97.09 0.88% | BATL 11.76 113.04% | QQQ 608.07 0.13% | HYG 80.28 -0.55% | PLTR 145.133 5.79% | SOFI 18.39 3.55% | MARA 9.45 5.70% | XLF 51.3 -0.25% | JDST 1.18 1.72% | SQQQ 70.59 -0.37% | INTC 45.5 -0.24% | ETHA 15.37 5.85% | TSLL 14.74 0.27% | TLT 89.61 -1.33% | TSLA 403.225 0.18% | LQD 110.92 -0.68% | BMNR 20.42 7.59% | IWM 263.82 0.92% | RIG 6.25 -3.55% | NIO 4.72 -3.08% | BKLN 20.21 0.02%

AMN Healthcare Services, Inc. (NYSE:AMN) Maintains Strong Position in Healthcare Staffing Industry

AMN Healthcare Services, Inc. (NYSE:AMN) is a leading player in the healthcare staffing industry, offering a wide range of workforce solutions and staffing services to healthcare facilities across the United States. The company competes with other healthcare staffing firms like Cross Country Healthcare and CHG Healthcare, providing services such as travel nurse staffing, locum tenens staffing, and allied staffing.

On August 11, 2025, BMO Capital maintained its "Outperform" rating for AMN, while keeping the action as "hold." At that time, AMN's stock price was $16.73. BMO Capital also adjusted its price target for AMN, lowering it from $27 to $22. This adjustment reflects a more cautious outlook on the stock's potential growth.

AMN reported its financial results for the second quarter of 2025, with a quarterly revenue of $658 million and an adjusted EBITDA of $58.3 million. Despite these strong figures, the company faced a GAAP loss of $3.02 per share due to noncash goodwill and intangible asset impairment charges totaling $128 million, or $2.81 per share. However, the adjusted earnings per share was $0.30, indicating underlying profitability.

The revenue for the quarter was near the high end of AMN's guidance, and the adjusted EBITDA margin exceeded expectations. Notably, AMN's allied staffing business surpassed its revenue projections, while other segments performed in line with expectations. This performance highlights the company's ability to meet and exceed its financial targets in certain areas.

Currently, AMN's stock price is $16.87, reflecting a decrease of 2.15% or $0.37. During the day, the stock fluctuated between a low of $16.54 and a high of $17.59. Over the past year, AMN has experienced a high of $59.19 and a low of $14.87. The company's market capitalization is approximately $645.9 million, with a trading volume of 174,961 shares on the NYSE.

Published on: August 11, 2025